HR 4449
118th Congress
House
Health
Advisory bodies
Congressional oversight
Manufacturing
Medical research
Prescription drugs
Research and development
Pharmaceutical Security Production Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 7, 2023
Referred to the Subcommittee on Health.
Jun 30, 2023
Referred to the House Committee on Energy and Commerce.
Jun 30, 2023
Introduced in House
Plain-English summary
Pharmaceutical Security Production Act
This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain.
The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products.
The commission terminates four years after the bill is enacted.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1